Sanarus raises $23m for breast cryoablation:
This article was originally published in Clinica
Executive Summary
Pleasanton, California cryoablation specialist Sanarus Medical has closed a $23m financing round that will help it commercialise its products. The company's Visica ultrasound-guided system to treat breast fibroadenomas - or benign tumours - minimally invasively received FDA marketing clearance in 2001; it employs cryosurgical technology developed by Endocare, of Irvine, California. Sanarus also markets a breast biopsy device called Cassi. The financing was led by Pequot Ventures and current investors including Alta Partners, Technology Funding and US Venture Partners participated.